Phenol

Phenol

SCHEMBL264361

[O-]c1ccccc1.[O-]c1ccccc1.[O-]c1ccccc1.[O-]c1ccccc1.[O-]c1ccccc1.[O-]c1ccccc1.[W+6]

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.41
CYP3A4 P08684 1/20 0.41
ALDH1A1 P00352 4/20 0.40
CA1 P00915 3/20 0.38
CA2 P00918 3/20 0.38
CA4 P22748 2/20 0.37
CA7 P43166 2/20 0.37
CA14 Q9ULX7 2/20 0.37
ORAI1 Q96D31 2/20 0.37
ORAI2 Q96SN7 2/20 0.37
ORAI3 Q9BRQ5 2/20 0.37
TRPV6 Q9H1D0 2/20 0.37
CA6 P23280 1/20 0.37
CA5A P35218 1/20 0.37
ENPP2 Q13822 1/20 0.37
CA5B Q9Y2D0 1/20 0.37
PCSK9 Q8NBP7 1/20 0.37
TSHR P16473 4/20 0.35
CA9 Q16790 2/20 0.35
LMNA P02545 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenol SCHEMBL4184679 0.96 TDP1 (0.44) TDP1CYP3A4ALDH1A1CA1CA2
Phenol SCHEMBL9442373 0.92 TDP1 (0.41) TDP1CYP3A4ALDH1A1CA1CA2
Phenol SCHEMBL993252 0.92 TDP1 (0.41) TDP1CYP3A4ALDH1A1CA1CA2
Phenol SCHEMBL12477517 0.92 TDP1 (0.41) TDP1CYP3A4ALDH1A1CA1CA2
Phenol SCHEMBL11214345 0.92 TDP1 (0.41) TDP1CYP3A4ALDH1A1CA1CA2
Phenol SCHEMBL3806092 0.92
Phenol SCHEMBL17709449 0.92
Phenol SCHEMBL17060450 0.92 TDP1 (0.41) TDP1CYP3A4ALDH1A1CA1CA2
Phenol SCHEMBL9187012 0.92 TDP1 (0.41) TDP1CYP3A4ALDH1A1CA1CA2
Phenol SCHEMBL150379 0.92 TDP1 (0.41) TDP1CYP3A4ALDH1A1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112566956-A Three-dimensional lattice structures comprising a working material, compositions comprising three-dimensional lattice structures, and methods and compositions for making the same 詹姆斯·F·布朗 2021-03-26 CN claimed
US-8318876-B1 Thermoset polymers via ring opening metathesis polymerization of functionalized oils U.S. DEPARTMENT OF ENERGY (US) 2012-11-27 US claimed
US-20100212216-A1 SUPPLYING TUNGSTEN TO A COMBUSTION SYSTEM OR COMBUSTION SYSTEM EXHAUST STREAM CONTAINING IRON AFTON CHEMICAL CORPORATION 2010-08-26 US claimed
US-4525468-A MAGNESIUM BIS(SILOXIDE) WITH TITANIUM TETRAALKOXIDE AND AN ALKOXIDE OF ANOTHER TRANSITION METAL, CHLORINATION E. I. DU PONT DE NEMOURS AND COMPANY (US) 1985-06-25 US claimed
US-12544749-B2 Method for preparing single-atom, atomic cluster or single-molecular catalyst for oxidative coupling of methane using chemical vapor deposition KOREA INSTITUTE OF ENERGY RESEARCH (KR) 2026-02-10 US disclosed
EP-4423168-B1 POLYETHER POLYMERIZATION PROCESS DOW GLOBAL TECHNOLOGIES LLC (US) 2025-12-10 EP disclosed
US-20250115711-A1 POLYETHER POLYMERIZATION PROCESS DOW GLOBAL TECHNOLOGIES LLC (US) 2025-04-10 US disclosed
US-12201971-B2 Polyether polymerization process DOW GLOBAL TECHNOLOGIES LLC (US) 2025-01-21 US disclosed
CN-119256414-A Electrode, battery cell and redox flow battery 住友电气工业株式会社 2025-01-03 CN disclosed
US-20240392068-A1 POLYETHER POLYMERIZATION PROCESS DOW GLOBAL TECHNOLOGIES LLC (US) 2024-11-28 US disclosed
EP-3622003-B1 POLYETHER POLYMERIZATION PROCESS DOW GLOBAL TECHNOLOGIES LLC (US) 2024-11-27 EP disclosed
US-12152104-B2 Polyether polymerization process DOW GLOBAL TECHNOLOGIES LLC (US) 2024-11-26 US disclosed
EP-0480447-B1 DCPD polymerization compositions HERCULES INC (US) 1997-08-27 EP disclosed
US-5385751-A Atmospheric pressure CVD process for preparing fluorine-doped tungsten oxide films FORD MOTOR COMPANY (US) 1995-01-31 US disclosed
US-5319042-A Feed composition of tungsten complex metathesis catalyst, dicyclopentadiene, catalyst activator HERCULES INCORPORATED (US) 1994-06-07 US disclosed
US-5298471-A Catalyst activator selected from organoaluminum, tin, silane, zinc or lead compounds HERCULES INCORPORATED (US) 1994-03-29 US disclosed
EP-0480447-A2 Pure tungsten oxyphenolate complexes as DCPD polymerization catalysts HERCULES INCORPORATED (US) 1992-04-15 EP disclosed
US-5082909-A Dicyclopentadiene, heat resistant, high impact polymer HERCULES INCORPORATED (US) 1992-01-21 US disclosed
US-5034246-A Pyrolysis of alkylamine tungstate compound on a substrate, electrochromism GENERAL MOTORS CORPORATION (US) 1991-07-23 US disclosed
US-4675357-A BIS/ALLYL CARBONATE/MONOMER PPG INDUSTRIES, INC. (US) 1987-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12544749-B2 Method for preparing single-atom, atomic cluster or single-molecular catalyst for oxidative coupling of methane using chemical vapor deposition SOD1, SCO2, POLM TDP1 3751/4885CYP3A4 1852/4885ALDH1A1 1410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.